Defining Optimal Health Range for Thyroid Function Based on the Risk of Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Context: Reference ranges of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) are defined by their distribution in apparently healthy populations (2.5th and 97.5th percentiles), irrespective of disease risk, and are used as cutoffs for defining and clinically managing thyroid dysfunction. Objective: To provide proof of concept in defining optimal health ranges of thyroid function based on cardiovascular disease (CVD) mortality risk. Design and Participants: In all, 9233 participants from the Rotterdam Study (mean age, 65.0 years) were followed up (median, 8.8 years) from baseline to date of death or end of follow-up period (2012), whichever came first (689 cases of CVD mortality). Main Outcomes: We calculated 10-year absolute risks of CVD mortality (defined according to the SCORE project) using a Fine and Gray competing risk model per percentiles of TSH and FT4, modeled nonlinearly and with sex and age adjustments. Results: Overall, FT4 level >90th percentile was associated with a predicted 10-year CVD mortality risk >7.5% (P = 0.005). In men, FT4 level >97th percentile was associated with a risk of 10.8% (P < 0.001). In participants aged ≥65 years, absolute risk estimates were <10.0% below the 30th percentile (∼14.5 pmol/L or 1.10 ng/dL) and ≥15.0% above the 97th percentile of FT4 (∼22 pmol/L or 1.70 ng/dL). Conclusions: We describe absolute 10-year CVD mortality risks according to thyroid function (TSH and FT4) and suggest that optimal health ranges for thyroid function can be defined according to disease risk and are possibly sex and age dependent. These results need to be replicated with sufficient samples and representative populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There is increasing evidence that variation in thyroid status within the reference range is a risk factor for disease burden.[115][116][117][118]”
From Hypothyroidism (2024) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
The burden of disease in older people and implications for health policy and practice
Prince, M. J., Wu, F., Guo, Y., Gutierrez Robledo, L. M., O'Donnell, M., Sullivan, R., & Yusuf, S. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61347-7 · Cited by 1,989 · cited 1×
“We selected CVD as the primary outcome of interest because it is a leading burden of disease, morbidity, and mortality (15).”
MethodJonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Self-citationThe Rotterdam Study: objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,395
2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877
Self-citationSurks, M. I., & Hollowell, J. G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1499 · Cited by 750
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686 · cited 1×
“The intraindividual set point was much tighter than the interindividual set point, meaning that within an individual, changes in time were much smaller than changes between individuals (33).”
BackgroundSubclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572
Self-citationQuantification of the completeness of follow-up
Clark, T. G., Altman, D. G., & Stavola, B. L. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08272-7 · Cited by 406
The Rotterdam Study: 2016 objectives and design update
Hofman, A., Brusselle, G. G. O., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Ikram, M. A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0082-x · Cited by 382
Self-citationMethods of data collection and definitions of cardiac outcomes in the Rotterdam Study
Leening, M. J. G., Kavousi, M., Heeringa, J., van Rooij, F. J. A., Verkroost-van Heemst, J., Deckers, J. W., Mattace-Raso, F. U. S., Ziere, G., Hofman, A., Stricker, B. H. C., et al. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9668-8 · Cited by 247 · cited 3×
“We performed sensitivity analyses using a Rotterdam Study2based definition for CVD mortality (16), additionally adjusting the TSH analyses for FT4 and vice versa, as well as additionally adjusting the analyses for cardiovascular risk factors used in the SCORE project charts (i.”
MethodThyroid Function in the Euthyroid Range and Adverse Outcomes in Older Adults
Cappola, A. R., Arnold, A. M., Wulczyn, K., Carlson, M., Robbins, J., & Psaty, B. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3586 · Cited by 201 · cited 1×
“The current study is not the first to report an association of FT4 with clinical events, whereas the association is lower or absent with TSH (3, 6, 21).”
BackgroundSelf-citationWerneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77588 · Cited by 184 · cited 1×
“One explanation could be that in euthyroid subjects, TSH predominantly reflects the pituitary-thyroid axis set point rather than disease risk (29), whereas independent of TSH, circulating FT4 (and subsequently free triiodothyronine acting intracellularly) represents the bioavailable thyroid hormone that can be taken u…”
BackgroundSubclinical Hypothyroidism and Cognitive Impairment: Systematic Review and Meta-Analysis
Pasqualetti, G., Pagano, G., Rengo, G., Ferrara, N., & Monzani, F. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2046 · Cited by 183
Rieben, C., Segna, D., da Costa, B. R., Collet, T.-H., Chaker, L., Aubert, C. E., Baumgartner, C., Almeida, O. P., Hogervorst, E., Trompet, S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2129 · Cited by 175
Self-citationWieberdink, R. G., Ikram, M. A., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9673-y · Cited by 162
Boucai, L., & Surks, M. I. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03390.x · Cited by 141 · cited 1×
“5 percentile, similar to reference ranges of other laboratory results and clinical tests.(24-26) Subcl inical and overt thyroid disease are subsequently defined by these biochemical and stati stical reference ranges which, in general, do not take future health and disease risks into accou nt.”
DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
Welsh, K. J., & Soldin, S. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0193 · Cited by 124 · cited 1×
“assays for FT4 are affected by changes in serum-binding proteins that occur in disease and pregnancy (34).”
BackgroundThyroid function characteristics and determinants: the Rotterdam study.
Chaker, L., Korevaar, T. I. M., Medici, M., Uitterlinden, A. G., Hofman, A., Dehghan, A., Franco, O. H., & Peeters, R. P. (2016) · Thyroid · doi:10.1089/thy.2016.0133 · Cited by 118
Self-citationThyroid function and the risk of dementia: The Rotterdam Study
Chaker, L., Wolters, F. J., Bos, D., Korevaar, T. I. M., Hofman, A., van der Lugt, A., Koudstaal, P. J., Franco, O. H., Dehghan, A., Vernooij, M. W., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003227 · Cited by 115
Self-citationSapin, R., & d’Herbomez, M. (2003) · Clinical Chemistry · doi:10.1373/49.9.1531 · Cited by 104 · cited 1×
“Absolute values of TSH and especially FT4 are assay dependent, but the different immunoassays of TSH or FT4 correlate well in nonpregnant adult populations (19, 20), as previously also shown in the Rotterdam Study (21).”
ResultJonklaas, J., Kahric-Janicic, N., Soldin, O. P., & Soldin, S. J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118752 · Cited by 101 · cited 1×
“Absolute values of TSH and especially FT4 are assay dependent, but the different immunoassays of TSH or FT4 correlate well in nonpregnant adult populations (19, 20), as previously also shown in the Rotterdam Study (21).”
ResultNormal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study
Chaker, L., Heeringa, J., Dehghan, A., Medici, M., Visser, W. E., Baumgartner, C., Hofman, A., Rodondi, N., Peeters, R. P., & Franco, O. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2480 · Cited by 100
Self-citationThyroid Function and Sudden Cardiac Death: A Prospective Population-Based Cohort Study
Chaker, L., van den Berg, M. E., Niemeijer, M. N., Franco, O. H., Dehghan, A., Hofman, A., Rijnbeek, P. R., Deckers, J. W., Eijgelsheim, M., Stricker, B. H. C., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020789 · Cited by 97
Self-citationBissell, M. G. (2010) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(09)79368-5 · Cited by 92
Chaker, L., Buitendijk, G. H., Dehghan, A., Medici, M., Hofman, A., Vingerling, J. R., Franco, O. H., Klaver, C. C., & Peeters, R. P. (2015) · BMC Medicine · doi:10.1186/s12916-015-0329-0 · Cited by 74 · cited 2×
“The current study is not the first to report an association of FT4 with clinical events, whereas the association is lower or absent with TSH (3, 6, 21).”
BackgroundResultSelf-citationShift of the TSH reference range with improved iodine supply in Northeast Germany
Ittermann, T., Khattak, R. M., Nauck, M., Cordova, C. M. M., & Völzke, H. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0898 · Cited by 70
Self-citationMortensen, M. B., Afzal, S., Nordestgaard, B. G., & Falk, E. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv251 · Cited by 64
Inoue, K., Tsujimoto, T., Saito, J., & Sugiyama, T. (2016) · Thyroid · doi:10.1089/thy.2016.0156 · Cited by 63
Thyrotropin Versus Age Relation as an Indicator of Historical Iodine Intake
van de Ven, A. C., Netea-Maier, R. T., Smit, J. W., Kusters, R., van der Stappen, J. W. J., Pronk-Admiraal, C. J., Buijs, M. M., Schoenmakers, C. H. H., Koehorst, S. G. A., de Groot, M. J. M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0574 · Cited by 33 · cited 1×
“Therefore, our approach to defining thyroid function adequacy, which focused on cardiovascular mortality, needs to be confirmed in similar populations and replicated in complementary populations, such as younger participants and other ethnicities, and in regions with different current and historical iodine status (35).”
Background
Research works printed but not linked: 3
- 1. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J, Thyroid Studies C. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304:1365-1374
- 4. Chaker L, Baumgartner C, den Elzen WP, Collet TH, Ikram MA, Blum MR, Dehghan A, Drechsler C, Luben RN, Portegies ML, Iervasi G, Medici M, Stott DJ, Dullaart RP, Ford I, Bremner A, Newman AB, Wanner C, Sgarbi JA, Dorr M, Longstreth WT, Jr., Psaty BM, Ferrucci L, Maciel RM, Westendorp RG, Jukema JW, Ceresini G, Imaizumi M, Hofman A, Bakker SJ, Franklyn JA, Khaw KT, Bauer DC, Walsh JP, Razvi S, Gussekloo J, Volzke H, Franco OH, Cappola AR, Rodondi N, Peeters RP, Thyroid Studies C. Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab 2016; 101:4270-4282
- 10. Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, Wirth CD, Peeters RP, Asvold BO, den Elzen WP, Luben RN, Imaizumi M, Bremner AP, Gogakos A, Eastell R, Kearney PM, Strotmeyer ES, Wallace ER, Hoff M, Ceresini G, Rivadeneira F, Uitterlinden AG, Stott DJ, Westendorp RG, Khaw KT, Langhammer A, Ferrucci L, Gussekloo J, Williams GR, Walsh JP, Juni P, Aujesky D, Rodondi N, Thyroid Studies C. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 2015; 313:2055-2065
Cited by
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
Jonklaas, J., & Razvi, S. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30371-1 · Cited by 100
Razvi, S., Bhana, S., & Mrabeti, S. (2019) · Journal of Thyroid Research · doi:10.1155/2019/4106816 · Cited by 90
“An alternative approach could be to define optimal ranges for TSH and FT4 based on risk engine-derived estimates of the risk of adverse cardiovascular outcomes, in a manner analogous to that used for setting treatment goals in the management of serum lipids [43].”
ResultSubclinical hypothyroidism in older individuals
Biondi, B., & Cappola, A. R. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00285-0 · Cited by 98
Self-citationTaylor, P. N., Lansdown, A., Witczak, J., Khan, R., Rees, A., Dayan, C. M., & Okosieme, O. (2023) · Thyroid Research · doi:10.1186/s13044-023-00149-5 · Cited by 72
“These considerations have generated intense debate as to whether the existing approach to establishing thyroid reference ranges should be refined [12, 13].”
Background
Metadata
- Authors
- Chaker, L., Korevaar, T. I. M., Rizopoulos, D., Collet, T.-H., Völzke, H., Hofman, A., Rodondi, N., Cappola, A. R., Peeters, R. P., & Franco, O. H.
- Affiliations
- Erasmus MC (NL)
- Centre Hospitalier Universitaire Vaudois (CH)
- Universitätsmedizin Greifswald (DE)
- University of Bern (CH)
- University of Pennsylvania (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-05-17
- Volume
- 102
- Issue
- 8
- Pages
- 2853-2861
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2616814370
- Cited by
- 33
- References
- 31
- Citations by year
- 2024: 2 · 2023: 6 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 2
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- SERVAL (Université de Lausanne) (acceptedVersion, other-oa)
- IRIS (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Open Access CRIS of the University of Bern
- Funders
- National Science Foundation
- Veracyte
- European Commission (HORIZON2020, 634453)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (167826)
- ZonMw (91212044)
- Erasmus Universiteit Rotterdam
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Nestec
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- thyroid function, thyroid-stimulating hormone, free thyroxine, cardiovascular mortality, reference values, competing risk model, sex differences, age differences, older adults, thyroid dysfunction
- MeSH terms
- Aged, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Male, Middle Aged, Reference Values, Risk, Thyroid Diseases, Thyroid Function Tests, Thyrotropin, Thyroxine, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.